Herrmann N - Search Results

1

Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery disease.

Swardfager W, Herrmann N, Dowlati Y, Oh PI, Kiss A, Walker SE, Lanctôt KL. Swardfager W, et al. Among authors: herrmann n. Psychoneuroendocrinology. 2009 Nov;34(10):1560-6. doi: 10.1016/j.psyneuen.2009.05.019. Epub 2009 Jun 21. Psychoneuroendocrinology. 2009. PMID: 19540675

2

From transmitters to treatment: the pharmacotherapy of behavioural disturbances in dementia.

Herrmann N, Lanctôt KL. Herrmann N, et al. Can J Psychiatry. 1997 Jun;42 Suppl 1:51S-64S. Can J Psychiatry. 1997. PMID: 9220129 Review.

3

The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis.

Mittmann N, Herrmann N, Einarson TR, Busto UE, Lanctôt KL, Liu BA, Shulman KI, Silver IL, Narango CA, Shear NH. Mittmann N, et al. Among authors: herrmann n. J Affect Disord. 1997 Dec;46(3):191-217. doi: 10.1016/s0165-0327(97)00107-9. J Affect Disord. 1997. PMID: 9547117

4

Effectiveness of gabapentin for the treatment of behavioral disorders in dementia.

Herrmann N, Lanctôt K, Myszak M. Herrmann N, et al. J Clin Psychopharmacol. 2000 Feb;20(1):90-3. doi: 10.1097/00004714-200002000-00015. J Clin Psychopharmacol. 2000. PMID: 10653214 Clinical Trial.

5

Donepezil for behavioural disorders associated with Lewy bodies: a case series.

Lanctôt KL, Herrmann N. Lanctôt KL, et al. Among authors: herrmann n. Int J Geriatr Psychiatry. 2000 Apr;15(4):338-45. doi: 10.1002/(sici)1099-1166(200004)15:4<338::aid-gps119>3.0.co;2-u. Int J Geriatr Psychiatry. 2000. PMID: 10767734

6

Probing peripheral and central cholinergic system responses.

Naranjo CA, Fourie J, Herrmann N, Lanctôt KL, Birt C, Yau KK. Naranjo CA, et al. Among authors: herrmann n. J Psychiatry Neurosci. 2000 Sep;25(4):325-36. J Psychiatry Neurosci. 2000. PMID: 11022397 Free PMC article. Clinical Trial.

7

Role of serotonin in the behavioral and psychological symptoms of dementia.

Lanctôt KL, Herrmann N, Mazzotta P. Lanctôt KL, et al. Among authors: herrmann n. J Neuropsychiatry Clin Neurosci. 2001 Winter;13(1):5-21. doi: 10.1176/jnp.13.1.5. J Neuropsychiatry Clin Neurosci. 2001. PMID: 11207325 Review.

8

Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease.

Lanctôt KL, Herrmann N, van Reekum R, Eryavec G, Naranjo CA. Lanctôt KL, et al. Among authors: herrmann n. Int J Geriatr Psychiatry. 2002 Jun;17(6):531-41. doi: 10.1002/gps.636. Int J Geriatr Psychiatry. 2002. PMID: 12112177 Clinical Trial.

9

Central serotonergic activity is related to the aggressive behaviors of Alzheimer's disease.

Lanctôt KL, Herrmann N, Eryavec G, van Reekum R, Reed K, Naranjo CA. Lanctôt KL, et al. Among authors: herrmann n. Neuropsychopharmacology. 2002 Oct;27(4):646-54. doi: 10.1016/s0893-133x(02)00339-1. Neuropsychopharmacology. 2002. PMID: 12377401

10

Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.

Lanctôt KL, Herrmann N, LouLou MM. Lanctôt KL, et al. Among authors: herrmann n. J Psychiatry Neurosci. 2003 Jan;28(1):13-26. J Psychiatry Neurosci. 2003. PMID: 12587847 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

676 results

Search Page

Filters